Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
This is GST-tagged recombinant RNF213 protein, expressed in E. coli, and supplied as a protein lysate. It is sufficient for use as a Western Blot standard and comes pre-loaded with Bromophenol blue dye.
Lyophilized from 0.1M Tris-HCl (pH 6.8) buffer containing 0.2M DTT, 4% SDS, 0.2% Bromophenol blue and 20% Sucrose.
RNF213 Protein, C17orf27 Protein, KIAA1618 Protein, KIAA1554 Protein, Mysterin Protein, MYSTR Protein, ALO17 Protein, Moyamoya disease 2 Protein, MYMY2 Protein, NET57 Protein, Ring finger protein 213 Protein
RNF213 is a protein containing a C3HC4-type RING finger domain, which is a specialized type of Zn-finger that binds two atoms of zinc and is thought to be involved in mediating protein-protein interactions. The protein also contains an AAA domain, which is associated with ATPase activity. This gene is a susceptibility gene for Moyamoya disease, a vascular disorder of intracranial arteries.